Patent · US Expired

Imidazoline receptor binding compounds

US6635668B1 · kind B1 · utility

9Cited by
10References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 22, 1998
Grant dateOct 21, 2003
Priority date
Expiry dateJul 22, 2018

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2500/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Pentamidine and analogs thereof have activity as imidazoline receptor binding compounds. A method of binding the imidazoline receptor, comprises contacting a bis-benzene to said imidazoline receptor in an amount effective to bind to said receptor, wherein said bis-benzene contains at least one amidine group (e.g., one or two). The contacting step may be carried out in vivo or in vitro. Contacting may be carried out with individual active compounds or with libraries of active compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.